GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...

Abbott announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR™ spinal cord stimulation (SCS) technology provides people with chronic pain, particularly ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

aDivision of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada bDivision of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, ON, Canada ...

Abbott Laboratories (NYSE ... driven by strong demand in international markets for our Eterna rechargeable spinal cord stimulation device. So in summary, we delivered another quarter of strong ...